As expected, cancer patients with higher TS expression levels had shorter DFS (Figure 1B, HR 1.4, log‐rank p < 0.001) and OS (Figure 1B, HR 1.5, log‐rank p < 0.001). This evidence concerns the gene TYMS and cancer.